Tests an adult intervention connecting protein turnover and mitochondrial quality control to organismal survival.
age clocks as common as step counts or accurate enough to be surrogate endpoints
Provides a physiological intervention result relevant to extracellular-matrix aging, while leaving the drug mechanism and human translation unresolved.
showing prevention of multiple chronic diseases of aging unambiguously proves the geroscience hypothesis, & since the diseases are big ones, it should generate a lot of press
broad reach helps popularize the basic idea of modifying aging / extending longevity
Shows that age-impaired regenerative cells can retain recoverable function under defined experimental conditions.
Combines stem-cell stimulation with control of the inflammatory niche and measures mechanical repair, beyond cell counts alone.
curated content meant specifically for lay audiences that communicates the science, the efficiency of the geroscience approach, and engages directly with common objections
celebrities and the entertainment industry help shape public opinion; celebrities have the wealth to be early adopters & sharper need for at least the appearance of youthfulness
Connects reversible immune metabolism to cognitive function.
Provides experimentally testable links between extracellular structure, tissue signaling, and lifespan.
Demonstrates experimentally that lifespan can be altered through a defined genetic pathway.
high use; in the press a lot, business/pharma/financial press & celebrity press
Tests intervention after substantial aging, alongside genetic evidence for the pathway.
if people perceive such clinics/doctors to be providing real value in reducing aging / extending longevity, it could drive big demand
directly demonstrates the superiority of the geroscience approach over the 1-diseases-at-a-time approach
Demonstrates that the cellular location of an antioxidant intervention can affect mammalian aging outcomes.
Links an age-altered signal from Paneth niche cells to a reversible defect in stem-cell-supported tissue repair.
Links an epigenetic intervention to functional tissue outcomes in a defined animal system.
most people have pets or know many people who do (more than half of US families have a dog or cat)
apeals to authority; analogous petitions or declarations had big reach & helped change public attitudes during the Covid pandemic
affects virtually all humans by age 50-60 & 80% by 40yo & is well known to be age related, so reversing it & obsoleting reading glasses would be an unambiguous rejuvenation example everyone would be aware of
X-Prize has global brand & prizes in general get lots of press (partially due to big headline $ value numbers)
Demonstrates that a pharmacological intervention begun late in life can alter mammalian survival, with replication across three sites and both sexes.
Connects a defined age-related stem-cell population shift with functional immune outcomes.
Connects maintenance of protein quality control with improved cellular and organ function during aging.
Tests a specific extracellular-matrix component through both loss and restoration experiments.
mice ore the most common lab animal used before translation to huamns, so tripling the remaining lifespan of already aged mice would show clearly aging's malleability
Provides causal experimental evidence connecting a senescent-cell population with selected age-associated pathologies.
visible to everyone
could grow to include a lot of people; directly engages with illogical reasoning
Shows how a mechanism-inspired intervention can be tested in humans with both positive and null findings reported.
rejuvenation of the entire body in one shot & will unquestionably generate enormous press
| Select up to four records | ||||
|---|---|---|---|---|
| Adult Parkin overexpression extended fruit-fly lifespan Tests an adult intervention connecting protein turnover and mitochondrial quality control to organismal survival. | Transgenic fruit-fly experiments | Inducing Parkin expression in adult Drosophila increased mean and maximum lifespan and reduced age-associated protein aggregation, alongside changes in mitochondrial dynamics and activity. | 2026-09-28 | |
| aging biomarkers age clocks as common as step counts or accurate enough to be surrogate endpoints | aging clocks not good enough yet for surrogate endpoints or mass DTC adoption like HRV | aging clocks, Biomarkers of Aging Consortium | — | |
| ALT-711 reduced arterial stiffness in a small older-monkey study Provides a physiological intervention result relevant to extracellular-matrix aging, while leaving the drug mechanism and human translation unresolved. | Small uncontrolled nonhuman-primate study | Six older rhesus macaques showed lower aortic pulse-wave velocity and altered ventricular function after ALT-711 treatment; vascular stiffness later returned toward baseline. | 2026-09-28 | |
| big healthspan trials showing prevention of multiple chronic diseases of aging unambiguously proves the geroscience hypothesis, & since the diseases are big ones, it should generate a lot of press | not started; still fundraising | TAME (Targeting Aging with MEtformin) trial | — | |
| biohackers, podcasters, & social media influencers broad reach helps popularize the basic idea of modifying aging / extending longevity | much broader reach than eg LRI (eg by 50-100x on YouTube), but no focus on biotech | Bryan Johnson, Peter Attia | — | |
| Combined biochemical and mechanical treatment restores aged mouse muscle stem-cell function Shows that age-impaired regenerative cells can retain recoverable function under defined experimental conditions. | Preclinical mouse cell-transplantation study | Transient p38 inhibition plus soft-hydrogel culture expanded functional aged muscle stem cells; transplantation improved regeneration and strength in injured aged mouse muscles. | 2026-09-28 | |
| Combined local BMP2 and CSF1 blockade restores fracture strength in aged mice Combines stem-cell stimulation with control of the inflammatory niche and measures mechanical repair, beyond cell counts alone. | Local mouse fracture-repair experiment; published 2021 | A hydrogel delivering BMP2 with low-dose CSF1 antagonism at femoral fractures restored day-21 mechanical strength in 24-month-old mice to the range measured in young controls. | 2026-09-28 | |
| consistent direct-to-the-public education curated content meant specifically for lay audiences that communicates the science, the efficiency of the geroscience approach, and engages directly with common objections | good content but still poor reach (only tens of thousands of unique monthly visitors) | Lifespan Research Institute (formerly Lifespan.io/ / Life Extension Advocacy Foundation) | — | |
| entertainer & celebrity engagement & education and/or popular movies/shows celebrities and the entertainment industry help shape public opinion; celebrities have the wealth to be early adopters & sharper need for at least the appearance of youthfulness | blockbuster movie depictions bad; positive movies have tiny reach so far; ALSAE new | ALSAE, documentaries: The Immortalists, Longevity Hackers; fiction: The Last Generation to Die | — | |
| EP2 blockade improves memory in aged mice Connects reversible immune metabolism to cognitive function. | Preclinical mouse study | EP2 inhibition restored immune-cell metabolism and improved hippocampal memory and synaptic plasticity in aged mice. | 2026-09-28 | |
| Extracellular-matrix remodeling can influence worm lifespan Provides experimentally testable links between extracellular structure, tissue signaling, and lifespan. | Preclinical nematode study | In C. elegans, collagen dynamics and a YAP-1-linked mechanical feedback circuit coupled matrix remodeling to longevity; disrupting the circuit reduced longevity responses. | 2026-09-28 | |
| Genetic control of lifespan in C. elegans Demonstrates experimentally that lifespan can be altered through a defined genetic pathway. | Animal genetic experiment; no human treatment claim | Kenyon and colleagues reported in 1993 that daf-2 mutations could more than double adult worm lifespan, with the effect requiring daf-16. | 2026-09-28 | |
| GLP-1 drugs high use; in the press a lot, business/pharma/financial press & celebrity press | ongoing clinical & financial success; lots of press; big pharma embrace | [well known & from outside the aging field, so not listed] | — | |
| Late-life IL-11 blockade extends median lifespan in mice Tests intervention after substantial aging, alongside genetic evidence for the pathway. | Preclinical mouse antibody and genetic studies | An anti-IL-11 antibody started at 75 weeks increased median lifespan in both sexes and improved several functional and metabolic measures. | 2026-09-28 | |
| longevity clinics/doctors going mainstream (see instead approved treatments & biomarkers entries) if people perceive such clinics/doctors to be providing real value in reducing aging / extending longevity, it could drive big demand | demand only high relative to the extremely poor supply; no mass reach yet | — | — | |
| many FDA approved treatments for aging pathologies label expanding or being widely prescribed off-label directly demonstrates the superiority of the geroscience approach over the 1-diseases-at-a-time approach | only a few approvals so far & no label expansion or mass off-label prescribing yet | see this site's phase 3 trials & approvals table for examples of approvals which have not yet label expanded | — | |
| Mitochondrial catalase overexpression extends lifespan in transgenic mice Demonstrates that the cellular location of an antioxidant intervention can affect mammalian aging outcomes. | Preclinical transgenic mouse study | Mice expressing catalase in mitochondria showed increased survival and reduced oxidative damage and selected age-associated pathology. | 2026-09-28 | |
| Notum inhibition improves intestinal repair in aged mice Links an age-altered signal from Paneth niche cells to a reversible defect in stem-cell-supported tissue repair. | Organoid experiments and short-term aged-mouse injury recovery | Genetic Notum targeting or Wnt supplementation restored aged-organoid function. Pharmacological Notum inhibition improved aged-mouse intestinal stem-cell capacity and recovery after chemotherapy-induced damage. | 2026-09-28 | |
| Partial reprogramming restores visual function in mouse experiments Links an epigenetic intervention to functional tissue outcomes in a defined animal system. | Preclinical; mouse eye models | Lu and colleagues expressed OSK factors in retinal ganglion cells and reported improved axon regeneration and visual function in aged mice and a glaucoma model. | 2026-09-28 | |
| pet life extension, especially dogs & cats most people have pets or know many people who do (more than half of US families have a dog or cat) | all still in trials | Loyal, Dog Aging Project, Rejuvenate Bio, Genflow Bio, Cat Health Co | — | |
| petitions / declarations apeals to authority; analogous petitions or declarations had big reach & helped change public attitudes during the Covid pandemic | many scientist signatories; no notable effect on public at large yet; 2700 DLD sigs | Dublin Longevity Declaration (DLD) | — | |
| presbyopia treatment affects virtually all humans by age 50-60 & 80% by 40yo & is well known to be age related, so reversing it & obsoleting reading glasses would be an unambiguous rejuvenation example everyone would be aware of | Lento pre-clinical | Lento Bio | — | |
| prizes X-Prize has global brand & prizes in general get lots of press (partially due to big headline $ value numbers) | in-progress, but will take several more years | X-Prize Healthspan ($101M) | — | |
| Rapamycin started at 600 days extends survival at three mouse-study sites Demonstrates that a pharmacological intervention begun late in life can alter mammalian survival, with replication across three sites and both sexes. | Three-site mouse survival study; published 2009 | Genetically heterogeneous male and female mice received rapamycin chow from 600 days of age. Age at 90% mortality increased by 14% in females and 9% in males across pooled sites. | 2026-09-28 | |
| Removing myeloid-biased stem cells improves aged-mouse antiviral responses Connects a defined age-related stem-cell population shift with functional immune outcomes. | Preclinical mouse study | Antibody-mediated depletion of myeloid-biased hematopoietic stem cells increased lymphoid progenitors and improved primary and secondary adaptive responses to viral infection in aged mice. | 2026-09-28 | |
| Restoring lysosomal protein clearance preserves aged mouse liver function Connects maintenance of protein quality control with improved cellular and organ function during aging. | Preclinical; transgenic mouse liver study | Zhang and Cuervo maintained a lysosomal receptor involved in chaperone-mediated autophagy in transgenic mice. | 2026-09-28 | |
| Restoring niche fibronectin improves aged-mouse muscle regeneration Tests a specific extracellular-matrix component through both loss and restoration experiments. | Mouse muscle-injury and niche-reconstitution experiments | Removing fibronectin from young regenerating muscle reduced muscle stem-cell numbers. Reconstituting fibronectin in the aged niche restored stem-cell activity and improved regeneration after injury. | 2026-09-28 | |
| robust mouse results mice ore the most common lab animal used before translation to huamns, so tripling the remaining lifespan of already aged mice would show clearly aging's malleability | RMR1 results not convincing enough; RMR2 still fundraising | RMR (Robust Mouse Rejuvenation) project by LEVF (Longevity Escape Velocity Foundation) | — | |
| Senescent-cell clearance delays pathology in progeroid mice Provides causal experimental evidence connecting a senescent-cell population with selected age-associated pathologies. | Preclinical; accelerated-aging mouse model | Baker and colleagues used an inducible genetic system to remove p16Ink4a-positive cells in a mouse model of accelerated aging. | 2026-09-28 | |
| skin rejuvenation visible to everyone | OneSkin commercial w/ pub'd papers; Aegle & Rubedo in phase 1 | Rubedo, Aegle Tx, OneSkin, Turn Bio | — | |
| social movements could grow to include a lot of people; directly engages with illogical reasoning | very small | Vitalism | — | |
| Urolithin A trial separates muscle-endurance signals from primary endpoints Shows how a mechanism-inspired intervention can be tested in humans with both positive and null findings reported. | Human randomized trial; limited functional evidence, not lifespan extension | A randomized placebo-controlled study in older adults reported improvement in selected muscle-endurance measures after urolithin A supplementation. Six-minute walk distance and maximal ATP production did not show significant between-group improvement. | 2026-09-28 | |
| whole-body transplants (effectively head/brain transplants) rejuvenation of the entire body in one shot & will unquestionably generate enormous press | only a couple historical examples, so not even done reliable in animals yet | Jean Hebert's book Replacing Aging is the canonical book that lays out the vision | — |